Company
Amaroq Therapeutics
Advancing the Future of Long Non-Coding RNA (lncRNA) Medicine
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Developing first-in-class therapies to precisely target disease-driving long non-coding RNAs (lncRNAs) in oncology and beyond
Loading relationship preview